InvestSMART

Singular Health Group Ltd (ASX:SHG)

ALERT: Price-sensitive ASX Announcement for SHG
Current share price for SHG : $0.180 -0.045 (-20%)+
Announcement
Release
28 Apr 2026 8:24AM
Price at Release
$0.225
Full Release
download
Summary
Singular Health Group Limited (ASX: SHG) reported strong progress in the quarter ending 31 March 2026. Key achievements include the deployment of additional 3DICOM MD® licences to Provider Network Solutions (PNS), receiving a significant payment from PNS, and the successful rollout of the 3DICOM™ platform at Life Radiology's Miami clinic. The company expanded into the U.S. education sector with agreements in Miami-Dade County Public Schools and Florida International University. Financially, the company ended the quarter with $10,015,000 in cash and equivalents, and despite a net cash outflow from operations, maintains a robust financial position with close to two years of cash runway. The quarter also saw engagement in regulatory advancements with FDA clearance for the 3DICOM MD® Cloud platform and participation in U.S. ONC interoperability discussions. Singular Health continues to focus on expanding its presence and securing new contracts in the U.S. healthcare market.
Key Points
  • Deployment of 500 3DICOM MD® licences to PNS
  • Post-quarter payment of USD$500,000 from PNS
  • Full deployment of 3DICOM™ Patient at Life Radiology
  • Execution of Miami-Dade County Public Schools agreement
  • Memorandum of Understanding with Florida International University
  • FDA 510(k) clearance for 3DICOM MD® Cloud platform
  • Cash at bank at the end of the quarter was $10,015,000
  • Net cash used in operating activities was $1,320,000
  • Continued focus on U.S. healthcare market expansion
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.